Bone Mineral Density and ADT
Increasingly, we are using androgen deprivation therapy (ADT) either alone or in combination with radiation therapy for the treatment of localized, high-risk, or the biochemical relapse of prostate cancer (recurrent pc). Many studies have clearly demonstrated that bone mineral density (BMD) loss is rapid, especially during the first year of ADT. As much as 4.6% [...]
